Stock Report

Dr. Reddy's announces the acquisition of MenoLabs®, a leading women's health and dietary supplements portfolio of brands



Posted On : 2024-01-03 16:19:59( TIMEZONE : IST )

Dr. Reddy's announces the acquisition of MenoLabs®, a leading women's health and dietary supplements portfolio of brands

Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as "Dr. Reddy's"), today announced that it has acquired MenoLabs® business, a leading women's health and dietary supplement branded portfolio from Amyris, Inc. ("Amyris") in Amyris' Chapter 11 sales process.

Dr. Reddy's acquired the entire MenoLabs supplements portfolio which includes seven branded products designed to provide health support and address symptoms of perimenopause and menopause. Brands include MenoFit™ and MenoGlow™ probiotics, Happy Fiber™ and Well Rested™ dietary supplements, Athena's Shield™ menopause support supplement, and Goodness Glow™ and Keep Glowing Gorgeous™ supplements for healthy aging support. The deal also includes the MenoLife® health tracker app which supports the product line and provides community, education, and information to consumers regarding menopause. MenoLabs portfolio of products is sold in the United States, primarily through the brand's own [https://menolabs.com] and other e-commerce marketplaces including Amazon and Walmart.

"The MenoLabs acquisition will serve as a catalyst to accelerate growth in this space and build upon our aspiration to lead in the fast-growing women's nutritional and wellness markets," says Marc Kikuchi, Chief Executive Officer for Dr. Reddy's in North America. "The acquisition complements Dr. Reddy's U.S. selfcare and wellness business portfolio of brands and addresses unmet needs of consumers for sciencebased, research-driven products that provide relief from the symptoms of menopause. For these and many other reasons, I believe we are well-positioned to successfully integrate and grow the business."

Shares of Dr. Reddy's Laboratories Limited was last trading in BSE at Rs. 5924.85 as compared to the previous close of Rs. 5819.05. The total number of shares traded during the day was 12551 in over 2634 trades.

The stock hit an intraday high of Rs. 5950.00 and intraday low of 5818.95. The net turnover during the day was Rs. 74237314.00.

Source : Equity Bulls

Keywords

DrReddysLaboratories INE089A01023 RDY Acquisition MenoLabs